Lipoatrophy with human insulin.
We describe a case of lipoatrophy that was secondary to human insulin. The patient had only ever been treated with human insulin, and the lipoatrophy appeared to partially resolve with continued use of the same insulin preparations. Possible underlying pathogenic mechanisms are discussed.
Jaap
A J
AJ
Department of Diabetes, Royal Infirmary of Edinburgh, U.K.
Horn
H M
HM
Tidman
M J
MJ
Walker
J D
JD
D000273:Adipose Tissue / Q000187:drug effects / Q000473:pathology*; D000328:Adult; D001284:Atrophy; D003922:Diabetes Mellitus, Type 1 / Q000188:drug therapy*; D005260:Female; D006801:Humans; D007328:Insulin / Q000009:adverse effects*; D011994:Recombinant Proteins / Q000009:adverse effects*
D007328:Insulin; D011994:Recombinant Proteins